FDA Website - FDA takes steps to streamline path for COVID-19 screening tools The FDA takes steps to streamline the path for COVID-19 screening tools announces a March 16, 2021 policy to accelerate EUAs for tests used in serial screening of asymptomatic individuals. It outlines a new supplemental EUA template allowing certain molecular, antigen, and at-home tests to be authorized for screening and OTC use based on strong symptomatic performance combined with serial testing. The update also provides guidance to schools, workplaces, and communities on selecting appropriate tests for screening programs. primary file regulatory fda-policy 2021-03-16_FDA Website - FDA takes steps to streamline path for COVID-19 screening tools.md regulatory/fda-policy/2021-03-16_FDA Website - FDA takes steps to streamline path for COVID-19 screening tools.md 2021_03_16 date converted 2024-06-20 website Public Domain 709 955 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url